|
Study cohort of 190 patients suffering from chronic inflammatory bowel diseases. |
|||
| Total population |
Crohn's Disease |
Ulcerative Colitis |
|
|
|
|||
| n (%) |
190 (100%) |
128 (67.4%) |
62 (32.6%) |
| age (years) ± SEM |
37 ± 10 |
36 ± 10 |
39 ± 10 |
| female n (%) |
85 (44.7%) |
64 (50.0%) |
21 (34%) |
| male n (%) |
106 (55.3%) |
64 (50.0%) |
42 (66%) |
| Body mass index (BMI) kg/m2 ± SEM |
23.8 ± 3.5 |
23.3 ± 3.6 |
24.7 ± 3.2 |
| C-reactive protein mg/dl ± SEM |
14.6 ± 13.5 |
15.1 ± 13.0 |
13.9 ± 14.4 |
| systemic steroids n (%) |
79 (41%) |
46 (36%) |
33 (53%) |
| topical steroids n (%) |
47 (25%) |
24 (18%) |
23 (37%) |
| other immuno-suppressants n (%) |
48 (25%) |
32 (24%) |
16 (25%) |
| Vienna classification [22] n (%): L1 |
- |
21 (16.4%) |
- |
| L2 |
- |
24 (18.8%) |
- |
| L3 |
- |
67 (52.3%) |
- |
| L4 |
- |
16 (12.5%) |
- |
| B1 |
- |
35 (27.3%) |
- |
| B2 |
- |
35 (27.3%) |
- |
| B3 |
- |
58 (45.4%) |
- |
|
Vienna classification: L1 = terminal ileum, L2 = colon, L3 = ilecolon, L4 = upper gastrointestinal tract; B1 = non-stricturin, non-penetrating, B2 = stricturing, B3 = penetrating | |||
Schäffler et al. Cardiovascular Diabetology 2007 6:3 doi:10.1186/1475-2840-6-3 |
|||